EASD. Weight loss 15% central focus in T2DM. The Lancet
|
02 oktober 2021 |
EASD. Revaskularisering säkert viid diabetes. NDR
|
02 oktober 2021 |
EASD. Real-Time CGM for All on Insulin: The Emerging Standard of Care
|
02 oktober 2021 |
EASD. Health Consequences of Frequent Hypoglycemia
|
02 oktober 2021 |
EASD. SGLT-2 Inhibitors Safe Effective in Older 2DM
|
02 oktober 2021 |
EASD. MiniMed 780G. Improvements in Time in Range
|
02 oktober 2021 |
EASD 2021 dag 4
|
01 oktober 2021 |
EASD 2021 dag 3
|
30 september 2021 |
EASD 2021 dag 2
|
29 september 2021 |
EASD. Abstracts orala presentationer fritt
|
29 september 2021 |